[1P-0525] High throughput screening for SARS-CoV-2 inhibitors using functional cell-based assay

^○Shogo Nakajima^{1, 2, 3}, Hirofumi Ohashi^{1, 2, 4}, Makoto Takeda⁵, Koichi Watashi^{1, 2, 4} (1.Department of Virology II, National Institute of Infectious Diseases, 2.Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, 3.Choju Medical Institute, Fukushimura Hospital, 4.Tokyo University of Science Graduate School of Science and Technology, 5.Department of Virology III, National Institute of Infectious Diseases)

g . Infection / Virus(4 . Animal and Plant Physiology, and Diseases)